Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.
AMCP welcomes the introduction of the Medicaid VBPs for Patients Act. The legislation would expand Medicaid access to novel therapies.
Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.
Hear from a panel of experts discussing how to navigate the landscape of food allergies.
On April 5, 2023, the Centers for Medicare and Medicaid Services (CMS) issued a Final Rule,
titled “Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare
Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan
Program, and Programs of All-Inclusive Care for the Elderly” (Final Rule).
Substance Abuse and Mental Health Services Administration (SAMHSA) within
the Department of Health and Human Services (“HHS”) issued a final rule on
Medications for the Treatment of Opioid Use Disorder (Final Rule), to be published
on Feb. 2, 2024.
On April 17, 2023, the Centers for Medicare & Medicaid Services (CMS) finalized the 2024
Notice of Benefit and Payment Parameters (NBPP).
